Literature DB >> 21071950

Improved visual hallucination by donepezil and occipital glucose metabolism in dementia with Lewy bodies: the Osaki-Tajiri project.

Masayuki Satoh1, Hiroyasu Ishikawa, Kenichi Meguro, Masashi Kasuya, Hiroshi Ishii, Satoshi Yamaguchi.   

Abstract

Deficits in the cholinergic system are pronounced in dementia with Lewy bodies (DLB) and are more severe in patients with visual hallucinations (VHs). The aim is to identify the occipital glucose metabolism patterns by positron emission tomography (PET) and the changes following donepezil treatment. 13 DLB patients with VHs were enrolled in the study. After the first FDG-PET study, 5 mg/day donepezil was administered orally, and a second PET study was performed 3 months later. After donepezil administration, VHs disappeared completely in 6 patients, and the PET studies revealed significantly decreased glucose metabolism in the medial occipital cortex. These results suggest that VHs in DLB were associated with impaired glucose metabolism in the medial occipital cortex. Donepezil treatment may modify regional glucose metabolism. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071950     DOI: 10.1159/000322121

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  16 in total

1.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

2.  Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.

Authors:  Arianna Sala; Silvia Paola Caminiti; Leonardo Iaccarino; Luca Beretta; Sandro Iannaccone; Giuseppe Magnani; Alessandro Padovani; Luigi Ferini-Strambi; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2019-07-19       Impact factor: 5.038

3.  Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.

Authors:  D Aarsland; C Ballard; A Rongve; M Broadstock; P Svenningsson
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 4.  Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.

Authors:  Paul Noufi; Rita Khoury; Sajeeka Jeyakumar; George T Grossberg
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

5.  Dementia with Lewy bodies: basis of cingulate island sign.

Authors:  Jonathan Graff-Radford; Melissa E Murray; Val J Lowe; Bradley F Boeve; Tanis J Ferman; Scott A Przybelski; Timothy G Lesnick; Matthew L Senjem; Jeffrey L Gunter; Glenn E Smith; David S Knopman; Clifford R Jack; Dennis W Dickson; Ronald C Petersen; Kejal Kantarci
Journal:  Neurology       Date:  2014-07-23       Impact factor: 9.910

Review 6.  Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Authors:  Michal Rolinski; Chris Fox; Ian Maidment; Rupert McShane
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 7.  Dementia with Lewy bodies - from scientific knowledge to clinical insights.

Authors:  Nikitas A Arnaoutoglou; John T O'Brien; Benjamin R Underwood
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

Review 8.  Magnetic resonance spectroscopy in the diagnosis of dementia with Lewy bodies.

Authors:  Radoslaw Magierski; Tomasz Sobow
Journal:  Biomed Res Int       Date:  2014-07-06       Impact factor: 3.411

9.  Detection of Low-Signal Pulvinar Areas Using Diffusion-Weighted Imaging in Patients with Dementia Experiencing Visual Hallucinations.

Authors:  Mayuko Sugiura; Masayuki Satoh; Ken-Ichi Tabei; Tomoki Saito; Mutsuki Mori; Makiko Abe; Hirotaka Kida; Masayuki Maeda; Hajime Sakuma; Hidekazu Tomimoto
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-09-29

10.  Visual cortical excitability in dementia with Lewy bodies.

Authors:  John-Paul Taylor; Michael Firbank; John T O'Brien
Journal:  Br J Psychiatry       Date:  2015-11-05       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.